PRELIMINARY SCIENTIFIC PROGRAMME & CALL FOR ABSTRACTS11 th ISNI Congress Day 26 th November 2012Morning Session8:30 am Main Hall: Plenary Symposium 2miRNA in neuroimmune diseases8:30 am Robert DarnellInvestigator, Rockefeller University, New York, NY, USAOverview of immune regulation in CNS9:15 am Alexander RudenskyMemorial SloanKettering Cancer Center, New York, NY, USA10:0010:30 am Coffee Break10:30 am – 12:00 pm Concurrent SymposiaRoom ARoom BRoom CNeuroimmunology of brain tumorsMichael WellerDepartment of Neurology, University Hospital Zürich, Germany“Targeting trans<strong>for</strong>ming growth factorβ in glioblastoma”Michael PlattenDepartment of Neurooncology, University of Heidelberg MedicalSchool, Germany“The aryl hydrocarbon receptor in tumor immunity:lessons from malignant glioma”Linda LiauNeurosurgery, David Geffen School of Medicine at UCLA,Los Angeles, CA, USA“Dendritic cellbased immunotherapy <strong>for</strong> glioma”Inflammation in neurodegenerative disordersZaal KokaiaLund Stem Cell Center University Hospital, SwedenAnnamaria VezzaniMario Negri Institute <strong>for</strong> Pharmacological Research, Milan, ItalyRegulatory T cells in neuroimmune diseasesDavid HaflerNeurology and Immunobiology, Yale University, New Haven, CT, USARoberto FurlanNeuroimmunology Unit, San Raffaele Scientific Institute,Milan, Italy and Women’s Hospital, Boston, MA, USA30
PRELIMINARY SCIENTIFIC PROGRAMME & CALL FOR ABSTRACTSAfternoon Session12:001:30 pm Lunch Break & Poster Session1:30 pm Main Hall: Plenary Lecture 2The NewsonDavis LectureVanda A LennonImmunology and Neurology, Mayo Clinic, Rochester, MN, USA2:304:00 pm Oral Plat<strong>for</strong>ms4:005:00 pm Poster Session5:006:00 pm Training Sessions 2Christopher LoveDepartment of Chemical Engineering, MIT, Cambridge, MA, USA31